To study the effect of Agastya haritaki Avaleha in reccurent upper respiratory track infection

" efficacy of Agastya haritaki Avaleha as an Immuno - Modulator in Reccurent URTI of Children- A Randomized open clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/041164

Enrollment

Registered

2022-03-16

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: The cases of recurrent URTI with the features mentioned in the criteria of selection of patients shall be included patients irrespective of sex occupation religion socio economic status and duration of illness children aged between 3-12 years will be included for study Recurrent URT infection with need of antibiotic for 3 times in last six months

Exclusion criteria

Exclusion criteria: patients above 12 years will be excluded from the study patient with nasal anatomical abnormalities will be excluded patient suffering from chronic systemic disease like tuberculosis and immuno compromised patients

Design outcomes

Primary

Measure	Time frame
Relief in symptoms like sneezing nasal discharge cough and fever by grading or scoring methodsTimepoint: Results are expected within a time period of 4 to 6 weeks	—

Secondary

Measure	Time frame
Relief from symptoms like nasal discharge and cough with sputum by grading or scoring methodsTimepoint: Results expected in 45 to 60 days	—

Countries

India

Contacts

Public ContactAbhaysing rajput

VAIDYA YAGYA DUTT SHARMA P G AYURVEDIC COLLEGE

drbalumaneri87@gmail.com7993470134

Outcome results